ProPublica

Journalism in the Public Interest

Cancel

Eli Lilly

Lilly, headquartered in Indianapolis, Ind., agreed in 2009 to pay $1.4 billion to settle criminal and civil allegations that it promoted Zyprexa for unapproved uses.

Eli Lilly began reporting payments for speaking, consulting, patient education programs and international education programs as of January 2009. Its first report included the total number of activities each doctor took part in, but that was removed in subsequent reports. In 2010, it added certain travel related expenses. In 2011, it added spending on research and meals. Lilly combines business travel and educational items into one category. Lilly maintains a separate log of payments to health professionals who are not doctors and is the only company to do so. Those payments are also included in Dollars for Docs.

See all Eli Lilly payments, or visit Eli Lilly's transparency page.

Notable drugs

  • Cymbalta (depression, generalized anxiety disorder, diabetic peripheral neuropathic pain, fibromyalgia, chronic osteoarthritis pain, chronic low back pain)
  • Humalog (diabetes)
  • Alimta (lung cancer, mesothelioma)
  • Evista (osteoporosis, lowering risk of invasive breast cancer)
  • Cialis (erectile dysfunction, benign prostatic hyperplasia)
  • Humulin (diabetes)
  • Forteo (osteoporosis)
  • Strattera (ADHD)
  • Effient (prevents strokes and heart attacks in patients who need to have a heart procedure called percutaneous coronary intervention)
  • Glucagon (hypoglycemia, diabetes)
  • Erbitux (colon cancer, advanced head and neck cancer)

Payment Reports

2009 Jan. to Dec.

Avg. Quarterly Total
Speaking $17,164,168 $68,656,671
Other $1,914,850 $7,659,398
Consulting $1,319,715 $5,278,860
$20,398,732 $81,594,929

2010 Jan. to Dec.

Avg. Quarterly Total
Speaking $15,369,387 $61,477,547
Other $1,766,455 $7,065,820
Travel $1,301,385 $5,205,539
Consulting $1,028,629 $4,114,517
$19,465,856 $77,863,423

2011 Jan. to Dec.

Avg. Quarterly Total
Research $37,493,283 $149,973,132
Speaking $11,857,521 $47,430,082
Meals $2,887,232 $11,548,929
Travel $1,683,754 $6,735,014
Consulting $469,597 $1,878,386
Adjustment -$5,280 -$21,119
$54,386,106 $217,544,424

2011 Jan. to Dec. Other Healthcare Professionals

Avg. Quarterly Total
Consulting $1,405,186 $5,620,743
Other $1,147,187 $4,588,746
Travel $375,318 $1,501,272
Speaking $126,375 $505,501
$3,054,066 $12,216,262

2012 Jan. to Dec.

Avg. Quarterly Total
Research $45,377,011 $181,508,042
Speaking $4,713,905 $18,855,621
Meals $1,840,716 $7,362,864
Travel $717,795 $2,871,178
Consulting $484,456 $1,937,823
Adjustment -$5,310 -$21,241
$53,128,572 $212,514,287

2012 Jan. to Dec. Other Healthcare Professionals

Avg. Quarterly Total
Other $709,800 $2,839,200
Speaking $697,146 $2,788,583
Travel $263,274 $1,053,095
Consulting $105,430 $421,721
Adjustment -$927 -$3,707
$1,774,723 $7,098,892

Total Payments by State

State Total
California $72,538,250
Florida $52,564,958
Texas $44,448,874
New York $41,198,265
Pennsylvania $30,744,714
Illinois $28,400,136
Ohio $23,688,761
Georgia $22,045,785
Missouri $19,926,815
North Carolina $18,413,280
Massachusetts $17,561,821
Indiana $16,474,820
New Jersey $15,769,660
Michigan $14,097,676
Tennessee $13,667,666
Washington $13,584,903
Arizona $11,713,072
Maryland $10,716,147
Connecticut $9,145,502
Virginia $8,963,888
Louisiana $8,286,676
Puerto Rico $8,221,416
Oregon $6,849,957
Wisconsin $6,876,956
Kentucky $6,518,519
Colorado $6,482,424
Minnesota $6,531,857
South Carolina $6,603,188
Kansas $6,181,354
Utah $6,091,715
Oklahoma $6,017,356
Alabama $5,510,906
Arkansas $4,682,874
Nevada $4,026,914
Nebraska $3,781,464
Iowa $3,727,575
Mississippi $3,617,860
Idaho $3,508,968
Rhode Island $3,247,894
New Mexico $3,023,203
New Hampshire $2,514,258
West Virginia $1,599,805
District of Columbia $1,502,515
Hawaii $1,464,392
North Dakota $1,369,866
Maine $1,183,253
Delaware $978,924
Montana $865,293
South Dakota $812,214
Vermont $799,410
Alaska $155,016
[Unknown State] $94,346
Wyoming $38,682